News

Neuro-diagnostic company Oculogica today announced the launch of OcuPro, the fastest roadside cannabis test with immediate results, and pilots with several police departments across the U.S.. Officers administer the 45-second long test and receive an immediate indication of recent cannabis use and impairment. The technology is based on studies in several hundred cannabis users which is in […]

Founder, Dr. Uzma Samadani is featured in a story by Sarah Philip at Leaps.org. Click here to read the full article. Using eye movements to diagnose a concussion has emerged as a promising technique since around 2010 Oculogica combined eye movements with AI to develop the EyeBOX to develop an unbiased objective diagnostic tool. “What’s so great

Oculogica Inc. announces publication of the initial 5-site study performed to obtain FDA Marketing Authorization for its EyeBOX technology as an aid in the diagnosis of concussion.  EyeBOX uses eye tracking to assess pupil size and position to determine whether a person has sustained damage to brain regions that control those functions.    The study, published in Frontiers

Oculogica Founder Dr. Uzma Samadani is featured in a story Elena Bergeron at the NY Times. Clickhere to read the full article. Concussions can cause much subtler symptoms, including headaches, sluggishnessand difficulty sleeping, some of which are not present immediately after a trauma.The absence of obvious symptoms makes the type of instant diagnosis that is

CEO Rosina Samadani is featured in a story by Geri Stengel at Forbes. Click here to read the fullarticle. Two sisters teamed up to develop and bring to market an EyeBOX—the firstobjective diagnostic for concussions. The algorithm-based test takes less than fourminutes, is non-invasive, and can be used with children and adults. Oculogica’sEyeBOX moves beyond

Oculogica is featured in a story by Ken Belson at the New York Times. Click here to read. Among the offices facing Lambeau Field are those of some of the nearly two dozen tech start-ups in which the team has invested. The Packers and Microsoft each contributed $5 million to a $25 million fund to incubate emerging

Oculogica, a leader in concussion diagnostics, announces that Justin Johnson has been promoted to the role of Vice President of Commercial Development. Justin has an impressive background in business development and sales management spanning 20 years. Highlighted by various roles at organizations such as Smith & Nephew, Biomet Orthopaedics, and Millennium Medical Technologies, where his

March 8, 2022 — Oculogica and Minnetronix announce a partnership to manufacture EyeBOX. Parents with children in sports often worry about concussions. It’s an anxiety that we are allaying with technology. The EyeBOX can help diagnose a possible concussion in less than four minutes — 220 seconds, to be precise. Rather than trusting a patient’s

The EyeBOX is the First FDA-cleared Objective Test for Concussion March 1, 2022 — Oculogica, a leader in concussion diagnostics, today announced  launch of the new EyeBOX device following FDA clearance earlier this year. The latest EyeBOX is lightweight, battery-operated, and small enough to fit in a backpack, making it easy to use in both clinical and

Oculogica, a leader in concussion diagnostics, today announced that David Lorek has joined the company as Senior Software Engineer.   David has over 25 years of experience in software design and developing systems in public safety, pre-clinical and clinical industries creating scalable, user-friendly solutions.  Prior to joining Oculogica, David worked in large and small companies in private